[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE137963T1 - Lh-rh-analoga enthaltende formulierungen - Google Patents

Lh-rh-analoga enthaltende formulierungen

Info

Publication number
ATE137963T1
ATE137963T1 AT92111535T AT92111535T ATE137963T1 AT E137963 T1 ATE137963 T1 AT E137963T1 AT 92111535 T AT92111535 T AT 92111535T AT 92111535 T AT92111535 T AT 92111535T AT E137963 T1 ATE137963 T1 AT E137963T1
Authority
AT
Austria
Prior art keywords
analogs
formulations containing
relates
aerosol formulations
suspension aerosol
Prior art date
Application number
AT92111535T
Other languages
English (en)
Inventor
Akwete L Adjei
James W Kesterson
Edwin S Johnson
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/934,874 external-priority patent/US4851211A/en
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE137963T1 publication Critical patent/ATE137963T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
AT92111535T 1986-11-25 1987-11-23 Lh-rh-analoga enthaltende formulierungen ATE137963T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/934,874 US4851211A (en) 1986-11-25 1986-11-25 LHRH analog formulations
US07/114,359 US4897256A (en) 1986-11-25 1987-11-04 LHRH analog formulations

Publications (1)

Publication Number Publication Date
ATE137963T1 true ATE137963T1 (de) 1996-06-15

Family

ID=26812097

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92111535T ATE137963T1 (de) 1986-11-25 1987-11-23 Lh-rh-analoga enthaltende formulierungen

Country Status (7)

Country Link
US (1) US4897256A (de)
EP (2) EP0275404B1 (de)
JP (1) JP2533586B2 (de)
AT (1) ATE137963T1 (de)
CA (1) CA1300009C (de)
DE (2) DE3785570T2 (de)
ES (2) ES2040727T3 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
US5011678A (en) * 1989-02-01 1991-04-30 California Biotechnology Inc. Composition and method for administration of pharmaceutically active substances
WO1994008599A1 (en) * 1992-10-14 1994-04-28 The Regents Of The University Of Colorado Ion-pairing of drugs for improved efficacy and delivery
JPH09501418A (ja) * 1993-07-19 1997-02-10 アムジエン・インコーポレーテツド エアゾル化タンパク質の安定化
US5711934A (en) * 1994-04-11 1998-01-27 Abbott Laboratories Process for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
US7572252B1 (en) * 1995-06-07 2009-08-11 Alza Corporation Electrotransport agent delivery method and apparatus
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5932547A (en) * 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
BR9710130A (pt) * 1996-07-03 1999-08-10 Alza Corp Formulações de peptídeos próticas não-aquosas
US5981489A (en) * 1996-07-18 1999-11-09 Alza Corporation Non-aqueous protic peptide formulations
ATE287257T1 (de) * 1997-01-16 2005-02-15 Massachusetts Inst Technology Zubereitung von partikelhaltigen arzneimitteln zur inhalation
EP1498115A1 (de) * 1997-01-16 2005-01-19 Massachusetts Institute Of Technology Zubereitung von partikelhaltigen Arzneimitteln zur Inhalation
US6099851A (en) * 1998-06-02 2000-08-08 Weisman; Kenneth M. Therapeutic uses of leuprolide acetate
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
DE10043509A1 (de) * 2000-09-01 2002-03-14 Asta Medica Ag Feste Peptidzubereitungen für die Inhalation und deren Herstellung
EP1345629A2 (de) 2000-12-29 2003-09-24 Advanced Inhalation Research, Inc. Inhalationspartikel mit verzögerter freigabe
US20030035774A1 (en) * 2001-07-18 2003-02-20 Adjei Akwete L. Salt/ion pair medicinal aerosol formulation
DE10214031A1 (de) * 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
ES2314451T3 (es) 2003-02-27 2009-03-16 Wisconsin Alumni Research Foundation Pmcol para el tratamiento de cancer de prostata.
WO2004110603A2 (en) * 2003-06-03 2004-12-23 Ferro Corporation Method for preparation of particles from solution-in-supercritical fluid or compressed gas emulsions
US20050287077A1 (en) * 2004-02-10 2005-12-29 James E. Shipley Process for preparing stable SOL of pharmaceutical ingredients and hydrofluorocarbon
JP2007534387A (ja) * 2004-04-23 2007-11-29 フィリップ・モリス・ユーエスエー・インコーポレイテッド エアゾール発生器及びエアゾール生成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3898329A (en) * 1971-09-17 1975-08-05 Sami I Said Vasoactive intestinal peptide, composition and method
GB1454105A (en) * 1972-11-04 1976-10-27 Hoechst Ag Preparation containing luteinizing hormone-releasing factor
DE2254061A1 (de) * 1972-11-04 1974-05-16 Hoechst Ag Lh-releasing hormon zur nasalen applikation
FR2320107A1 (fr) * 1975-08-05 1977-03-04 Anvar Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4438029A (en) * 1978-01-19 1984-03-20 Research Corporation Synthetic peptides
JPS5819669B2 (ja) * 1978-10-28 1983-04-19 白井松新薬株式会社 新規生理活性ペプチド化合物及びその製造法
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
AU565912B2 (en) * 1982-12-10 1987-10-01 Syntex (U.S.A.) Inc. Lhrh antagronist preparations for intra-nasal administration
US4481191A (en) * 1983-03-30 1984-11-06 The Regents Of The University Of California Method for controlling blood pressure
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions

Also Published As

Publication number Publication date
EP0510731B1 (de) 1996-05-15
EP0275404B1 (de) 1993-04-21
EP0510731A1 (de) 1992-10-28
DE3751811D1 (de) 1996-06-20
JP2533586B2 (ja) 1996-09-11
ES2040727T3 (es) 1993-11-01
ES2089301T3 (es) 1996-10-01
EP0275404A1 (de) 1988-07-27
DE3785570T2 (de) 1993-11-18
DE3785570D1 (de) 1993-05-27
US4897256A (en) 1990-01-30
DE3751811T2 (de) 1996-11-28
CA1300009C (en) 1992-05-05
JPS63211237A (ja) 1988-09-02

Similar Documents

Publication Publication Date Title
DE3751811D1 (de) LH-RH-Analoga enthaltende Formulierungen
ATE100668T1 (de) Chemische formulierungen.
DE69004731D1 (de) Hilfsmittel enthaltende verdünnbare Formulierungen von Nachlaufherbiziden.
IL89921A0 (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
DE3779053D1 (de)
DK631688D0 (da) 2',3'-dideoxy-2'-fluornucleosider, fremstillingen deraf samt praeparater indeholdende samme
TR23424A (tr) 1,2,3,6-tetrahidro-5-nitro-pirimidin tuerevleri
IT1203945B (it) Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine
ZW1187A1 (en) Insecticidal trifluromethyl alkane derivatives
BR8703717A (pt) Formulacao pesticida do tipo suspensao estavel
DE3874594D1 (de) Gaenzlich waesserige formulierungen von organophosphorpestiziden.
IL90220A0 (en) Anticoagulant peptide alcohols
NO871639L (no) Vertikal arkstabler.
IT8522963A0 (it) Composizione disinfettante per via aerea.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
DE3762800D1 (de) Benzhydrylthiomethan-derivate enthaltende therapeutische zusammensetzungen.
IT8722397A0 (it) Composizioni cosmetiche.
DK116687A (da) Farmaceutisk praeparat indeholdende aenovantroneae
ATE88341T1 (de) Zusammensetzungen enthaltend lhrh-analoga.
FI884483A (fi) 1 (2h)-ftalatsinoler som cellskyddande medel.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
SE8705030D0 (sv) Substans p-analoger
ES267525Y (es) "cuadrupedo andador de juguete".
DE3779302D1 (de) Ubidecarenon enthaltende kosmetische zusammensetzungen.
ATE76279T1 (de) Ubidecarenon enthaltende kosmetische zusammensetzungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee